[Treatment trials with K 33 suppositories in impotentia coeundi].
D015068:17-Ketosteroids / Q000652:urine; D000328:Adult; D062365:Aminobenzoates / Q000627:therapeutic use*; D001120:Arginine / Q000627:therapeutic use*; D001224:Aspartic Acid / Q000627:therapeutic use; D007172:Erectile Dysfunction / Q000188:drug therapy* / Q000652:urine; D005938:Glucocorticoids / Q000652:urine; D006801:Humans; D008110:Liver Extracts / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009297:Nasal Mucosa; D010179:Pancreas; D010919:Placebos; D014020:Tissue Extracts / Q000627:therapeutic use*; D014815:Vitamins / Q000627:therapeutic use*
D015068:17-Ketosteroids; D062365:Aminobenzoates; D005938:Glucocorticoids; D008110:Liver Extracts; D010919:Placebos; D014020:Tissue Extracts; D014815:Vitamins; D001224:Aspartic Acid; D001120:Arginine
Therapieversuche mit K 33 Suppositorien bei Impotentia coeundi.